AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-86
Results: 1-25/86
Letter to the editor
Authors: Pauk, J Buchwald, D Corey, L
Citation: J. Pauk et al., Letter to the editor, J CLIN VIRO, 21(1), 2001, pp. 103-104
Herpes simplex virus shedding and plasma human immunodeficiency virus RNA levels in coinfected women. (vol 33, pg 885, 2001)
Authors: Augenbraun, M Corey, L Reichelderfer, P
Citation: M. Augenbraun et al., Herpes simplex virus shedding and plasma human immunodeficiency virus RNA levels in coinfected women. (vol 33, pg 885, 2001), CLIN INF D, 33(8), 2001, pp. 1445-1445
Human herpesvirus 6 reactivation and encephalitis in allogeneic bone marrow transplant recipients
Authors: Zerr, DM Gooley, TA Yeung, L Huang, ML Carpenter, P Wade, JC Corey, L Anasetti, C
Citation: Dm. Zerr et al., Human herpesvirus 6 reactivation and encephalitis in allogeneic bone marrow transplant recipients, CLIN INF D, 33(6), 2001, pp. 763-771
Herpes simplex virus shedding and plasma human immunodeficiency virus RNA levels in coinfected women
Authors: Augenbraun, M Corey, L Reichelderfer, P Wright, DJ Burns, D Koelle, DM Robison, E Cohen, M
Citation: M. Augenbraun et al., Herpes simplex virus shedding and plasma human immunodeficiency virus RNA levels in coinfected women, CLIN INF D, 33(6), 2001, pp. 885-890
Virological, clinical, and ophthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation
Authors: Crippa, F Corey, L Chuang, EL Sale, G Boeckh, M
Citation: F. Crippa et al., Virological, clinical, and ophthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation, CLIN INF D, 32(2), 2001, pp. 214-219
Inhibition of apoptosis by primary isolates of herpes simplex virus
Authors: Jerome, KR Fox, R Chen, Z Sarkar, P Corey, L
Citation: Kr. Jerome et al., Inhibition of apoptosis by primary isolates of herpes simplex virus, ARCH VIROL, 146(11), 2001, pp. 2219-2225
QS-21 promotes an adjuvant effect allowing for reduced antigen dose duringHIV-1 envelope subunit immmunization in humans
Authors: Evans, TG McElrath, MJ Matthews, T Montefiori, D Weinhold, K Wolff, M Keefer, MC Kallas, EG Corey, L Gorse, GJ Belshe, R Graham, BS Spearman, PW Schwartz, D Mulligan, MJ Goepfert, P Fast, P Berman, P Powell, M Francis, D
Citation: Tg. Evans et al., QS-21 promotes an adjuvant effect allowing for reduced antigen dose duringHIV-1 envelope subunit immmunization in humans, VACCINE, 19(15-16), 2001, pp. 2080-2091
Seroepidemiology of human herpesvirus 8 among young men who have sex with men
Authors: Diamond, C Thiede, H Perdue, T MacKellar, D Valleroy, LA Corey, L
Citation: C. Diamond et al., Seroepidemiology of human herpesvirus 8 among young men who have sex with men, SEX TRA DIS, 28(3), 2001, pp. 176-183
Effect of condoms on reducing genital herpes transmission - Reply
Authors: Wald, A Link, K Corey, L Langenberg, A
Citation: A. Wald et al., Effect of condoms on reducing genital herpes transmission - Reply, J AM MED A, 286(17), 2001, pp. 2096-2096
Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women
Authors: Wald, A Langenberg, AGM Link, K Izu, AE Ashley, R Warren, T Tyring, S Douglas, JM Corey, L
Citation: A. Wald et al., Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women, J AM MED A, 285(24), 2001, pp. 3100-3106
Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections
Authors: Kimberlin, DW Lin, CY Jacobs, RF Powell, DA Corey, L Gruber, WC Rathore, M Bradley, JS Diaz, PS Kumar, M Arvin, AM Gutierrez, K Shelton, M Weiner, LB Sleasman, JW de Sierra, TM Weller, S Soong, SJ Kiell, J Lakeman, FD Whitley, RJ
Citation: Dw. Kimberlin et al., Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections, PEDIATRICS, 108(2), 2001, pp. 230-238
Mucosal shedding of human herpesvirus 8. Reply
Authors: Corey, L Pauk, J Wald, A
Citation: L. Corey et al., Mucosal shedding of human herpesvirus 8. Reply, N ENG J MED, 344(9), 2001, pp. 691-692
Activation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus
Authors: Vieira, J O'Hearn, P Kimball, L Chandran, B Corey, L
Citation: J. Vieira et al., Activation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus, J VIROLOGY, 75(3), 2001, pp. 1378-1386
Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants
Authors: Boeckh, M Berrey, MM Bowden, RA Crawford, SW Balsley, J Corey, L
Citation: M. Boeckh et al., Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants, J INFEC DIS, 184(3), 2001, pp. 350-354
Long-term entecavir treatment results in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infection
Authors: Colonno, RJ Genovesi, EV Medina, I Lamb, L Durham, SK Huang, ML Corey, L Littlejohn, M Locarnini, S Tennant, BC Rose, B Clark, JM
Citation: Rj. Colonno et al., Long-term entecavir treatment results in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infection, J INFEC DIS, 184(10), 2001, pp. 1236-1245
Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus type 1 vaccine with or without gp120: A phase 2 study in higher- and lower-risk volunteers
Authors: Belshe, RB Stevens, C Gorse, GJ Buchbinder, S Weinhold, K Sheppard, H Stablein, D Self, S McNamara, J Frey, S Flores, J Excler, JL Klein, M El Habib, R Duliege, AM Harro, C Corey, L Keefer, M Mulligan, M Wright, P Celum, C Judson, F Mayer, K McKirnan, D Marmor, M Woody, G
Citation: Rb. Belshe et al., Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus type 1 vaccine with or without gp120: A phase 2 study in higher- and lower-risk volunteers, J INFEC DIS, 183(9), 2001, pp. 1343-1352
Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection
Authors: Schacker, T Little, S Connick, E Gebhard, K Zhang, ZQ Krieger, J Pryor, J Havlir, D Wong, JK Schooley, RT Richman, D Corey, L Haase, AT
Citation: T. Schacker et al., Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection, J INFEC DIS, 183(4), 2001, pp. 555-562
Cellular and humoral immune responses to a canarypox vaccine containing human immunodeficiency virus type 1 Env, Gag, and Pro in combination with RGP120
Authors: Corey, L
Citation: L. Corey, Cellular and humoral immune responses to a canarypox vaccine containing human immunodeficiency virus type 1 Env, Gag, and Pro in combination with RGP120, J INFEC DIS, 183(4), 2001, pp. 563-570
Cytomegalovirus (CMV) DNA load in plasma for the diagnosis of CMV disease before engraftment in hematopoietic stem-cell transplant recipients
Authors: Limaye, AP Huang, ML Leisenring, W Stensland, L Corey, L Boeckh, M
Citation: Ap. Limaye et al., Cytomegalovirus (CMV) DNA load in plasma for the diagnosis of CMV disease before engraftment in hematopoietic stem-cell transplant recipients, J INFEC DIS, 183(3), 2001, pp. 377-382
Quantitation of BK virus load in serum for the diagnosis of BK virus-associated nephropathy in renal transplant recipients
Authors: Limaye, AP Jerome, KR Kuhr, CS Ferrenberg, J Huang, ML Davis, CL Corey, L Marsh, CL
Citation: Ap. Limaye et al., Quantitation of BK virus load in serum for the diagnosis of BK virus-associated nephropathy in renal transplant recipients, J INFEC DIS, 183(11), 2001, pp. 1669-1672
Treatment of primary human immunodeficiency virus type 1 infection with potent antiretroviral therapy reduces frequency of rapid progression to AIDS
Authors: Berrey, MM Schacker, T Collier, AC Shea, T Brodie, SJ Mayers, D Coombs, R Krieger, J Chun, TW Fauci, A Self, SG Corey, L
Citation: Mm. Berrey et al., Treatment of primary human immunodeficiency virus type 1 infection with potent antiretroviral therapy reduces frequency of rapid progression to AIDS, J INFEC DIS, 183(10), 2001, pp. 1466-1475
HSV and glycoprotein J inhibit caspase activation and apoptosis induced bygranzyme B or Fas
Authors: Jerome, KR Chen, Z Lang, R Torres, MR Hofmeister, J Smith, S Fox, R Froelich, CJ Corey, L
Citation: Kr. Jerome et al., HSV and glycoprotein J inhibit caspase activation and apoptosis induced bygranzyme B or Fas, J IMMUNOL, 167(7), 2001, pp. 3928-3935
CDS CTL from genital herpes simplex lesions: Recognition of viral tegumentand immediate early proteins and lysis of infected cutaneous cells
Authors: Koelle, DM Chen, HBB Gavin, MA Wald, A Kwok, WW Corey, L
Citation: Dm. Koelle et al., CDS CTL from genital herpes simplex lesions: Recognition of viral tegumentand immediate early proteins and lysis of infected cutaneous cells, J IMMUNOL, 166(6), 2001, pp. 4049-4058
Herpes simplex inhibits the capacity of lymphoblastoid B cell lines to stimulate CD4(+) T cells
Authors: Barcy, S Corey, L
Citation: S. Barcy et L. Corey, Herpes simplex inhibits the capacity of lymphoblastoid B cell lines to stimulate CD4(+) T cells, J IMMUNOL, 166(10), 2001, pp. 6242-6249
Role for HLA class II molecules in HIV-1 suppression and cellular immunityfollowing antiretroviral treatment
Authors: Malhotra, U Holte, S Dutta, S Berrey, MM Delpit, E Koelle, DM Sette, A Corey, L McElrath, MJ
Citation: U. Malhotra et al., Role for HLA class II molecules in HIV-1 suppression and cellular immunityfollowing antiretroviral treatment, J CLIN INV, 107(4), 2001, pp. 505-517
Risultati: 1-25 | 26-50 | 51-75 | 76-86